Novel Small Volume Blood Collection Device Launched at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

Image: VERIstic Collection Device enables comfortable blood collection with robotic high-throughput processing (Photo courtesy of Rhinostics)

A new device focused on small volume blood collection that was launched at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo marks a breakthrough in automated sample collection technologies.

At AACC 2022, Rhinostics, Inc. (Boston, MA, USA) introduced the patent-pending VERIstic Collection Device which is ideal for use in at-home and clinician-assisted collection methods and is a highly efficient, high-throughput replacement for antibody, hormone and protein detection, sexually transmitted infections (STIs), dried blood spot (DBS) cards, genetic testing, clinical trials, and other applications enabled by a simple finger prick collection.

This first of its kind collection device combines tried-and-true capillary blood collection with an integrated, automation-ready cap to save time, money, and hassles in a hands-free workflow when the sample reaches the laboratory. For patients and clinicians, the collection is rapid, simple, and comfortable. Once the finger is pricked with a lancet, 50 µL of blood is instantly wicked up the unique and patent-pending 3-sided capillary tube. The tube is screwed into its matching transport tube for shipment to the laboratory.

When it reaches the laboratory, 96 samples can be accessioned in seconds through 2D barcodes located on the transport tube bottom followed by robotic decapping of the samples, rapid elution of the sample, and automated liquid handling technologies. With gentle agitation, blood elutes from the capillary tube and is immediately ready for processing while lab technicians are free to focus their attention elsewhere. The VERIstic enables efficient, hands-free and low labor workflows. VERIstic is suited for a range of applications including other small volume body fluids, blood monitoring, wound care, clinical trials, and a number of home- or clinic-based sample collection needs.

“We’re very excited to bring this truly unique and simple innovation to the blood collection market,” said Cheri Walker, PhD, President and CEO of Rhinostics. “Finally, patients and clinicians can be assured of comfortable metered blood collection, where the clear capillary allows the collector to monitor collection and laboratories gain consistent blood collection combined with cost and time-saving efficiencies during processing through automated decapping and robotic sample processing.”

Related Links:
Rhinostics, Inc.